CLINICAL_TRIALS
research
· 2026-01-20
Clinical Trial Update: V-IMMUNE® for Immune Thrombocytopenia [Phase 3]
Summary
A Phase 3 clinical trial of V-IMMUNE for immune thrombocytopenia is actively recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. | Conditions: Immune Thrombocytopenia (ITP) | Phase 3 | Status: RECRUITING